A Novel Gene Therapy Targeting APOE4 Associated Alzheimer’s Disease

Time: 11:30 am
day: Day One: Track B AM

Details:

  • The role of APOE in the pathogenesis of Alzheimer’s disease
  • The basis of a gene therapy approach in APOE4-associated Alzheimer’s disease
  • The Phase 1 clinical trial in APOE4 homozygotes with Alzheimer’s disease

Speakers: